New AMA policies focus on GLP-1 coverage, resisting corporate medicine
Healthcare
Source: healthcaredive.com
Stay updated with breaking news from Payers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data indicates cardiovascular protective benefits from taking the obesity drug Wegovy. It’s unclear if this data will convince payers to change their coverage policies.
Healthcare